T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
XPEL
XPEL
$1.39B
| $333K | ﹤0.01% |
6,328
-83
| -1% | -$5.13K |
|
|
SGFY
2502
DELISTED
Signify Health, Inc.
SGFY
| $331K | ﹤0.01% |
18,247
-1,291
| -7% | -$18.5K |
|
|
VELO
2503
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
| $331K | ﹤0.01% |
33,986
| – | – |
|
|
AGEN
2504
Agenus
AGEN
$315M
| $330K | ﹤0.01% |
6,829
+648
| +10% | +$35K |
|
2505
Brookfield Renewable
BEPC
$6.66B
| $327K | ﹤0.01% |
7,461
-4,401
| -37% | -$163K |
|
2506
Lindsay Corp
LNN
$1.17B
| $327K | ﹤0.01% |
2,080
+148
| +8% | +$20.4K |
|
2507
Park Aerospace
PKE
$811M
| $325K | ﹤0.01% |
24,873
+4,415
| +22% | +$59.3K |
|
2508
Veru
VERU
$46M
| $325K | ﹤0.01% |
6,739
+160
| +2% | +$8.69K |
|
2509
Willdan Group
WLDN
$1.29B
| $323K | ﹤0.01% |
10,520
-3,755
| -26% | -$117K |
|
2510
Lexicon Pharmaceuticals
LXRX
$1.04B
| $322K | ﹤0.01% |
153,932
+10,300
| +7% | +$28.6K |
|
2511
WisdomTree
WT
$3.44B
| $321K | ﹤0.01% |
54,741
+3,110
| +6% | +$17.8K |
|
|
BAND
2512
Bandwidth Inc
BAND
$1.74B
| $320K | ﹤0.01% |
9,885
-1,452
| -13% | -$69.5K |
|
|
AAIC
2513
DELISTED
Arlington Asset Investment Corp.
AAIC
| $320K | ﹤0.01% |
92,100
| – | – |
|
2514
TaskUs
TASK
$667M
| $319K | ﹤0.01% |
8,300
+2,000
| +32% | +$70.4K |
|
|
AVID
2515
DELISTED
Avid Technology Inc
AVID
| $318K | ﹤0.01% |
9,117
+768
| +9% | +$23.8K |
|
|
CANO
2516
DELISTED
Cano Health, Inc.
CANO
| $318K | ﹤0.01% |
501
+174
| +53% | +$110K |
|
2517
ACM Research
ACMR
$5.65B
| $317K | ﹤0.01% |
15,300
+5,700
| +59% | +$143K |
|
|
ANAT
2518
DELISTED
American National Group, Inc. Common Stock
ANAT
| $317K | ﹤0.01% |
1,674
-736
| -31% | -$139K |
|
2519
Gorman-Rupp
GRC
$2.11B
| $316K | ﹤0.01% |
8,798
+1,356
| +18% | +$52.6K |
|
2520
Talos Energy
TALO
$2.58B
| $316K | ﹤0.01% |
20,009
-7,654
| -28% | -$101K |
|
|
CNSL
2521
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $316K | ﹤0.01% |
53,639
+1,768
| +3% | +$11.8K |
|
|
ACR
2522
ACRES Commercial Realty
ACR
$101M
| $312K | ﹤0.01% |
23,265
-2,700
| -10% | -$33.3K |
|
|
BCLI
2523
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $312K | ﹤0.01% |
6,200
| – | – |
|
2524
Blink Charging
BLNK
$87.1M
| $309K | ﹤0.01% |
11,696
+1,813
| +18% | +$42.6K |
|
2525
eHealth
EHTH
$38.8M
| $308K | ﹤0.01% |
24,826
-146,389
| -86% | -$2.52M |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.